StemCells, Inc. · Palo Alto, CA United States (NASDAQ: STEM)
| 3155 Porter Dr. | Phone: 650-475-3100 |
| Palo Alto, CA | Fax: 650-475-3101 |
| 94304 | |
| United States | 
Map This Company |
StemCells, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and macular degeneration, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition to its CNS research, StemCells is also studying liver cells, hoping to find treatments for diseases such as hepatitis and liver cancer.
StemCells, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: STEM Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 74 |
Executives
23 executives listed for StemCells, Inc.'s Palo Alto, CA location.
| Chairman | John Schwartz | |
|---|---|---|
| President, CEO, and Director | Martin McGlynn | |
| SVP Development and Operations | Stewart Craig |